Clinical Trials | January 17, 2026
GCCL and OPIS forge global clinical trial alliance
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
The trial supports the potential for another chemotherapy backbone option that may be paired with encorafenib plus cetuximab in this patient population
Vanda strongly disputes the FDA’s reasoning
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
Subscribe To Our Newsletter & Stay Updated
